文献速递复苏、休克与脓毒症创伤与烧伤

成人危重出血大量输血定义的系统综述

Definitions of massive transfusion in adults with critical bleeding: a systematic review.
PubMed 文献 · Crit Care · 2023-07-05
一句话结论已发表RCT最常用大量输血定义为24小时内输注≥10单位红细胞,但各研究定义差异大,且均未纳入血浆、血小板等成分。

该系统综述检索截至2022年8月11日的多个数据库,纳入30项RCT(19项已发表、11项正在进行),旨在明确成人危重出血大量输血(MT)的定义。已发表试验最常见场景为创伤,正在进行试验最常见为产科。共识别15种不同MT定义,几乎均以设定时间内的红细胞(RBC)数量界定,无一定义纳入血浆、血小板或其他止血制剂。已完成试验最常用定义为24小时内输注≥10单位RBC(9/19,均为创伤),正在进行试验则多用3-5单位RBC(n=7),输血时间定义不清或未提供(n=5)。作者认为任何共识定义应反映纳入不同血液成分/制剂的需要,并就不同临床场景是否采用「一刀切」方法达成一致。

要点

  • 已完成RCT最常用的大量输血定义为24小时内输注≥10单位红细胞(9/19项,均为创伤人群)。
  • 正在进行RCT多采用3-5单位红细胞定义(n=7),但输血时间定义不清或未提供(n=5)。
  • 共识别15种不同的大量输血定义,在输血量和时间窗切点上差异很大。
  • 几乎全部定义仅以设定时间内的红细胞数量界定,无一定义纳入血浆、血小板或其他止血制剂。
  • 已发表试验最常见场景为创伤,正在进行试验最常见为产科。

适用人群与场景

  • 成人重大出血且已接受或预计接受大量输血的患者,涵盖任何临床场景;纳入研究须为RCT并明确大量输血定义作为纳入标准或结局指标。

诊断标准与关键阈值

  • 大量输血定义共15种,切点和时间窗差异很大;已完成RCT最常用为24小时内输注≥10单位红细胞(9/19项,均为创伤);正在进行RCT多为3-5单位红细胞(n=7),输血时间定义不清或未提供(n=5)。

研究设计与关键结果

  • 系统综述纳入30项RCT(19项已发表、11项正在进行),从8458条去重文献中筛选;已发表试验最常见场景为创伤,正在进行试验最常见为产科;共识别15种大量输血定义,几乎均以设定时间内红细胞数量界定,无一定义纳入血浆、血小板或其他止血制剂。
  • 已完成试验最常用定义为24小时内输注≥10单位红细胞(9/19,均为创伤);正在进行试验最常用为3-5单位红细胞(n=7),输血时间定义不清或未提供(n=5)。

证据类型、等级与局限

  • 证据类型:系统综述(检索MEDLINE、Embase、Cochrane CENTRAL、PubMed、CINAHL、Transfusion Evidence Library,并检索CENTRAL、ClinicalTrials.gov、WHO ICTRP获取正在进行试验,检索至2022年8月11日)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为任何共识定义应反映纳入不同血液成分/制剂用于大量输血的需要,并就不同临床场景是否采用「一刀切」方法达成一致。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Definitions for massive transfusion (MT) vary widely between studies, contributing to challenges in interpretation of research findings and practice evaluation. In this first systematic review, we aimed to identify all MT definitions used in randomised controlled trials (RCTs) to date to inform the development of consensus definitions for MT.

METHODS: We systematically searched the following databases for RCTs from inception until 11 August 2022: MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Cumulative Index to Nursing and Allied Health Literature, and Transfusion Evidence Library. Ongoing trials were sought from CENTRAL, ClinicalTrials.gov, and World Health Organisation International Clinical Trials Registry Platform. To be eligible for inclusion, studies had to fulfil all the following three criteria: (1) be an RCT; (2) include an adult patient population with major bleeding who had received, or were anticipated to receive, an MT in any clinical setting; and (3) specify a definition for MT as an inclusion criterion or outcome measure.

RESULTS: Of the 8,458 distinct references identified, 30 trials were included for analysis (19 published, 11 ongoing). Trauma was the most common clinical setting in published trials, while for ongoing trials, it was obstetrics. A total of 15 different definitions of MT were identified across published and ongoing trials, varying greatly in cut-offs for volume transfused and time period. Almost all definitions specified the number of red blood cells (RBCs) within a set time period, with none including plasma, platelets or other haemostatic agents that are part of contemporary transfusion resuscitation. For completed trials, the most commonly used definition was transfusion of ≥ 10 RBC units in 24 h (9/19, all in trauma), while for ongoing trials it was 3-5 RBC units (n = 7), with the timing for transfusion being poorly defined, or in some trials not provided at all (n = 5).

CONCLUSIONS: Transfusion of ≥ 10 RBC units within 24 h was the most commonly used definition in published RCTs, while lower RBC volumes are being used in ongoing RCTs. Any consensus definitions should reflect the need to incorporate different blood components/products for MT and agree on whether a 'one-size-fits-all' approach should be used across different clinical settings.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Lin VS, Sun E, Yau S, et al. Definitions of massive transfusion in adults with critical bleeding: a systematic review. Crit Care. 2023. PMID: 37407998. doi:10.1186/s13054-023-04537-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。